The effect of micronutrient supplementation on disease progression and death in simian immunodeficiency virus-infected juvenile male rhesus macaques

Journal of Infectious Diseases

Volumn 192, Issue 2, 2005, Pages 311-318

  Goldin, Barry R ^a   Li, Wenjun ^b   Mansfield, Keith ^c   Woods, Margo ^a   Wanke, Christine ^a   Freeman, Lisa ^d   Shevitz, Abby ^a   Gualtieri, Lisa ^a   Bussell, Sarah ^c   Gorbach, Sherwood L ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; FOLIC ACID; IRON; NICOTINIC ACID; PYRIDOXINE; RETINOL; RIBOFLAVIN; SELENIUM; THIAMINE; TRACE ELEMENT; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE COURSE; MACACA; MALE; MORTALITY; NONHUMAN; NUTRITIONAL REQUIREMENT; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS LOAD;

ANIMALS; BODY MASS INDEX; BODY WEIGHT; BONE DENSITY; DIETARY SUPPLEMENTS; MACACA MULATTA; MICRONUTRIENTS; NUTRITIONAL REQUIREMENTS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SURVIVAL ANALYSIS;

EID: 22244463888     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/430951     Document Type: Article

References (31)

1. Chariot P, Dubreuil-Lemaire ML, Zhou JY, et al. Muscle involvement in human immunodeficiency virus-infected patients is associated with marked selenium deficiency. Muscle Nerve 1997; 20:386-9.
2. Look MP, Rockstroh JK, Roo GS, et al. Serum selenium plasma glutathione (GSH) and erythrocyte glutathione peroxidase (GSH-PX) levels in asymptomatic versus symptomatic human immunodeficiency virus-1 (HIV-1) infection. Eur J Clin Nutr 1997; 51:266-72.
3. Constans J, Pellegrin JL, Sergeant C, et al. Serum selenium predicts outcome in HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10:392.
4. Baum MK, Shor-Posner G, Lai S, et al. High risk of HIV-related mortality is associated with selenium deficiency. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 15:370-4.
5. Bica I, Tang AM, Skinner S, et al. Use of complementary and alternative therapies by patients with human immunodeficiency virus disease in the era of highly active antiretroviral therapy. J Altern Complement Med 2003; 9:65-76.
6. Knippels HM, Weiss JJ. Use of alternative medicine in a sample of HIV-positive gay men: an exploratory study of prevalence and user characteristics. AIDS Care 2000; 12:435-46.
7. Fairfield KM, Eisenberg DM, Davis RB, Libman H, Phillips RS. Patterns of use, expenditures, and perceived efficacy of complementary and alternative therapies in HIV-infected patients. Arch Intern Med 1998; 158:2257-64.
8. Southwell H, Valdez H, Lederman M, Gripshover B. Use of alternative therapies among HIV-infected patients at an urban tertiary care center. J Acquir Immune Defic Syndr 2002; 31:119-20.
9. Xu XM, Carlson BA, Grimm TA, et al. Rhesus monkey simian immunodeficiency virus infection as a model for assessing the role of selenium in AIDS. J Acquir Immune Defic Syndr 2002; 31:453-63.
10. Freeman LM, Mansfield KG, Lackner AA, et al. Survival and failure to thrive in the SIV-infected juvenile rhesus monkey. J Acquir Immune Defic Syndr 1999; 22:119-23.
11. Freeman LM, Mansfield KG, Goldin B, et al. Body-composition changes in the simian immunodeficiency virus-infected juvenile rhesus macaque. J Infect Dis 2004; 189:2010-5.
12. Sharkey SJ, Sharkey KA, Sutherland LR, Church DL. Nutritional status and food intake in human immunodeficiency virus infection. J Acquir Immune Defic Syndr 1992; 5:1091-8.
13. Schwenk A, Hoffer-Belitz E, Jung B, et al. Resting energy expenditure, weight loss, and altered body composition in HIV infection. Nutrition 1996; 12:595-601.
14. Grinspoon S, Corcoran C, Miller K, et al. Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting. J Clin Endocrinol Metab 1997; 82:1332-7.
15. Mulligan K, Tai VW, Schambelan M. Cross-sectional and longitudinal evaluation of body composition in men with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 15:43-8.
16. Arpadi SM, Horlick MNB, Wang J, Cuff P, Barnji M, Kotler DP. Body composition in prepubertal children with human immunodeficiency virus type 1 infection. Arch Pediatr Adolesc Med 1998; 152:688-93.
17. Miller TL, Evans SJ, Orav EJ, Morris V, McIntosh K, Winter HS. Growth and body composition in children infected with the human immunodeficiency virus-1. Am J Clin Nutr 1993; 57:588-92.
18. Institute for Laboratory Animal Research, National Research Council. Guide for the care and use of laboratory animals. Washington, DC: National Academy Press, 1996.
19. National Research Council. Nutrient requirements of nonhuman primates. Washington, DC: National Academy of Sciences, 1978.
20. Fawzi WW, Msamanga GI, Hunter D, et al. Randomized trial of vitamin supplements in relation to transmission of HIV-1 through breastfeeding and early child mortality. AIDS 2002; 16:1935-44.
21. Fawzi WW, Msamanga GI, Spiegelman D, et al. A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med 2004; 351:23-32.
22. Tang AM, Graham NMH, Sack AJ. Effects of micronutrient intake in survival in human immunodeficiency virus type I infection. Am J Epidemiol 1996; 143:1244-56.
23. Baum MK, Shor-Posner G, Lu Y, et al. Micronutrients and HIV-1 disease progression. AIDS 1995; 9:1051-6.
24. Suryanarayana K, Wiltrout TA, Vasquez GM, et al. Plasma SIV RNA viral load determination by real-time quantification of product generation in reverse transcriptional-polymerase chain reaction. AIDS Res Hum Retroviruses 1998; 14:183-9.
25. Efron B, Tibshirani R. An introduction to the bootstrap. 1st ed. New York: Chapman & Hall, 1993:436.
26. Semba RD, Tang AM. Micronutrients and the pathogenesis of human immunodeficiency virus infection. Brit J Nutr 1999; 81:181-9.
27. 12 levels in patients infected with human immunodeficiency virus. Am J Hematol 1995; 49:318-22.
28. Hathcock JN, Hattan DG, Jenkins MY, et al. Evaluation of vitamin A toxicity. Am J Clin Nutr 1990; 52:183-202.
29. Weber C, Belge P, von Hundelshousen P, et al. Differential chemokine receptor expression and function in human monocyte subpopulations. J Leukoc Biol 2000; 67:699-704.
30. Kitano K, Baldwin GC, Raines MA, Golde DW. Differentiating agents facilitate infection of myeloid leukemia cell lines by monocytotrophic HIV-1 strains. Blood 1990; 76:1980-8.
31. Turpin JA, Vaugo M, Meltzer MS. Enhanced HIV-1 replication in retinoid-treated monocytes. J Immunol 1992; 148:2539-46.